Molecular cancer therapeutics

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

期刊適用範圍

Molecular Cancer Therapeutics strives to be the top choice for publishing the best science in the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms. While the journal's main focus is on small molecule and protein drugs, other molecular entities may be considered.

影響因子

Molecular Cancer Therapeutics 最新的影響因子為5.599 (2012)

Molecular Cancer Therapeutics最新的影響因子為5.226 (2011)

Molecular Cancer Therapeutics最新的影響因子為5.225 (2010)